Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

We evaluated the impact of achieving a rapid response in 840 newly diagnosed multiple myeloma patients from 2004 to 2015. Rates of very good partial response (VGPR) or better were 29% (240/840) after 2 cycles of treatment, 42% (350/840) after 4 cycles of treatment, and 66% (552/840) as best response...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Tandon, Nidhi, Sidana, Surbhi, Rajkumar, S. Vincent, Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Kapoor, Prashant, Gonsalves, Wilson I., Dispenzieri, Angela, Kourelis, Taxiarchis V., Warsame, Rahma, Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi Lisa, Kyle, Robert A., Leung, Nelson, Go, Ronald S., Lust, John A., Russell, Stephen J., Kumar, Shaji K.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2019
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6418495/
https://ncbi.nlm.nih.gov/pubmed/30824418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018022806
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars